13F HOLDINGS REPORT
Frazier Life Sciences Management, L.P.
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0001892134-25-000005
Total Value
$2.19B
Positions
47
Other Managers
0
Confidential Omitted
No
Holdings (47)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 16,116,418 | $329.9M | 15.08% |
| 2 | MIRUM PHARMACEUTICALS INC | MIRM | 6,795,121 | $306.1M | 13.99% |
| 3 | VERONA PHARMA PLC | 925050106 | 3,457,850 | $219.5M | 10.03% |
| 4 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 8,785,284 | $137.4M | 6.28% |
| 5 | BRIDGEBIO PHARMA INC | BBIO | 3,800,457 | $131.4M | 6.00% |
| 6 | KRYSTAL BIOTECH INC | KRYS | 688,460 | $124.1M | 5.67% |
| 7 | DISC MEDICINE INC | IRON | 1,754,834 | $87.1M | 3.98% |
| 8 | TARSUS PHARMACEUTICALS INC | TARS | 1,397,527 | $71.8M | 3.28% |
| 9 | TREVI THERAPEUTICS INC | TRVI | 10,259,409 | $64.5M | 2.95% |
| 10 | PHATHOM PHARMACEUTICALS INC | PHAT | 10,109,279 | $63.4M | 2.90% |
| 11 | KALVISTA PHARMACEUTICALS INC | KALV | 4,887,867 | $56.4M | 2.58% |
| 12 | MAZE THERAPEUTICS INC | MAZE | 4,129,001 | $45.5M | 2.08% |
| 13 | MBX BIOSCIENCES INC | MBX | 5,985,347 | $44.2M | 2.02% |
| 14 | RHYTHM PHARMACEUTICALS INC | RYTM | 678,760 | $36.0M | 1.64% |
| 15 | SOLENO THERAPEUTICS INC | SLNO | 499,159 | $35.7M | 1.63% |
| 16 | REVOLUTION MEDICINES INC | RVMDW | 997,455 | $35.3M | 1.61% |
| 17 | SAVARA INC | SVRA | 11,462,301 | $31.8M | 1.45% |
| 18 | AGIOS PHARMACEUTICALS INC | AGIO | 1,069,854 | $31.3M | 1.43% |
| 19 | ERASCA INC | ERAS | 22,575,851 | $30.9M | 1.41% |
| 20 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 658,715 | $23.9M | 1.09% |
| 21 | ASCENDIS PHARMA A/S | ASND | 133,333 | $20.8M | 0.95% |
| 22 | VAXCYTE INC | PCVX | 539,405 | $20.4M | 0.93% |
| 23 | ALKERMES PLC | ALKS | 601,129 | $19.8M | 0.91% |
| 24 | PALVELLA THERAPEUTICS INC NE | PVLA | 690,012 | $19.3M | 0.88% |
| 25 | CG ONCOLOGY INC | CGON | 770,000 | $18.9M | 0.86% |
| 26 | MEREO BIOPHARMA GROUP PLC | MREO | 7,819,863 | $17.6M | 0.80% |
| 27 | MERUS N V | N5749R100 | 373,100 | $15.7M | 0.72% |
| 28 | AVIDITY BIOSCIENCES INC | 05370A108 | 525,000 | $15.5M | 0.71% |
| 29 | HILLEVAX INC | 43157M102 | 10,617,062 | $15.4M | 0.70% |
| 30 | DYNE THERAPEUTICS INC | DYN | 1,443,341 | $15.1M | 0.69% |
| 31 | ZAI LAB LTD | ZLAB | 350,000 | $12.6M | 0.58% |
| 32 | IMMUNOCORE HLDGS PLC | IMCR | 301,170 | $8.9M | 0.41% |
| 33 | ORIC PHARMACEUTICALS INC | ORIC | 1,410,193 | $7.9M | 0.36% |
| 34 | ACADIA PHARMACEUTICALS INC | ACAD | 470,338 | $7.8M | 0.36% |
| 35 | DESIGN THERAPEUTICS INC | DSGN | 1,953,547 | $7.5M | 0.34% |
| 36 | ROCKET PHARMACEUTICALS INC | RCKTW | 1,079,025 | $7.2M | 0.33% |
| 37 | AUTOLUS THERAPEUTICS PLC | AUTL | 4,623,324 | $7.2M | 0.33% |
| 38 | ORUKA THERAPEUTICS INC | ORKA | 583,327 | $6.0M | 0.27% |
| 39 | ALLOGENE THERAPEUTICS INC | ALLO | 3,868,750 | $5.6M | 0.26% |
| 40 | IMMATICS N.V | IMTX | 1,247,911 | $5.6M | 0.26% |
| 41 | COGENT BIOSCIENCES INC | COGT | 936,576 | $5.6M | 0.26% |
| 42 | ADVERUM BIOTECHNOLOGIES INC | 00773U207 | 1,069,244 | $4.7M | 0.21% |
| 43 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 500,333 | $4.5M | 0.21% |
| 44 | MACROGENICS INC | MGNX | 3,175,665 | $4.0M | 0.18% |
| 45 | LEXEO THERAPEUTICS INC | LXEO | 955,515 | $3.3M | 0.15% |
| 46 | SILENCE THERAPEUTICS PLC | SLNCF | 1,148,591 | $3.2M | 0.15% |
| 47 | ELEVATION ONCOLOGY INC | 28623U101 | 5,993,579 | $1.6M | 0.07% |